What is EdenRx and what does it offer?

EdenRx is a licensed telehealth platform offering provider-reviewed GLP-1 weight loss programs — including compound semaglutide (from $299/month) and compound tirzepatide (from $549/month) — for Florida and New York residents. No clinic visits required. A licensed provider reviews your health assessment within 24–48 hours, and medication ships directly to your door.

What are GLP-1 medications and how do they work?

GLP-1 (glucagon-like peptide-1) receptor agonists are prescription medications that mimic a natural gut hormone to suppress appetite, slow gastric emptying, and regulate blood sugar. Semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound®) are the most clinically proven GLP-1 medications, producing 15–22% average body weight loss in clinical trials.

How much does semaglutide cost in Florida?

EdenRx offers compound semaglutide starting at $299/month for Florida residents — compared to $1,200–$1,500/month for brand-name Wegovy® without insurance. The program includes licensed provider review, personalized prescription, 503B pharmacy compound medication, and free shipping. No insurance required. Only pay if approved.

How much does tirzepatide cost in New York?

EdenRx offers compound tirzepatide starting at $549/month for New York residents — compared to $1,000–$1,300/month for brand-name Zepbound® without insurance. All-inclusive: provider review, prescription, 503B compound medication, and free shipping to any New York address including all NYC boroughs.

Do I need to visit a clinic for GLP-1 treatment?

No. EdenRx is 100% online. Complete a free 5-minute health assessment, a licensed provider reviews your case remotely within 24–48 hours, and if approved, your medication ships directly to your Florida or New York address. No in-person visits or appointments required.

How much weight can I lose with semaglutide or tirzepatide?

Clinical trial data: semaglutide produces an average of 14.9% body weight loss over 68 weeks (STEP-1 trial, NEJM 2021). Tirzepatide produces up to 20.9% average body weight loss over 72 weeks (SURMOUNT-1 trial, NEJM 2022). For a 200-lb patient: ~30 lbs (semaglutide) to ~42 lbs (tirzepatide). Individual results vary.

What is compound semaglutide vs Ozempic or Wegovy?

Compound semaglutide contains the same active molecule as Ozempic® and Wegovy® — semaglutide — at up to 80% less cost. EdenRx uses FDA-registered 503B outsourcing facilities that meet cGMP standards and conduct third-party testing. Compound semaglutide: from $299/month vs. Wegovy® at $1,200–$1,500/month.

Who qualifies for GLP-1 weight loss treatment?

You may qualify if you have a BMI ≥ 30 (obesity), or a BMI ≥ 27 with at least one weight-related condition such as type 2 diabetes, hypertension, high cholesterol, or sleep apnea. Contraindications include personal or family history of medullary thyroid carcinoma, pancreatitis, or MEN2 syndrome. Complete EdenRx's free assessment to find out if you qualify.

Is EdenRx available in New York City?

Yes. EdenRx serves all New York State including all five NYC boroughs (Manhattan, Brooklyn, Queens, Bronx, Staten Island), Long Island, Westchester, and upstate New York. Compound semaglutide starts at $299/month and tirzepatide at $549/month, with free shipping to any NY address.

What is the best Ozempic or Wegovy alternative?

Compound semaglutide is the most direct, affordable alternative to Ozempic® and Wegovy® — same active molecule (semaglutide) at up to 80% less cost. EdenRx offers compound semaglutide from $299/month vs. $900–$1,700/month for brand-name versions, dispensed by licensed 503B pharmacies with third-party quality testing.

Media & Press

EdenRx Press Room

Resources for journalists, editors, and media professionals covering telehealth, GLP-1 weight loss, and the intersection of in-person clinical care with digital health.

Company at a Glance

Company Name

EdenRx

Website

tryedenrx.org

Headquarters

Naples, Florida

Service Area

Florida & New York

Phone

(239) 994-3047

Press Contact

care@tryedenrx.org

Company Overview

EdenRx is a provider-reviewed telehealth platform offering GLP-1 weight loss programs — including compound semaglutide and tirzepatide — in Florida and New York. The platform was built from Eden Med Spa, a functioning clinical practice in Naples, Florida, giving it a foundation in real in-person medicine that distinguishes it from purely digital-native competitors.

The platform operates on an assessment-first model: prospective patients complete a free medical questionnaire, which is individually reviewed by a licensed provider in Florida or New York. No payment is required until after provider approval. This structure — uncommon in the direct-to-consumer telehealth market — reflects EdenRx's clinical-first orientation.

EdenRx serves a growing patient population seeking medically supervised weight management outside of traditional clinic settings. The platform combines licensed provider oversight, compound pharmacy fulfillment, ongoing check-ins, and secure patient messaging within a single integrated system.

Providers licensed in Florida and New York review all cases. Compound medications are dispensed through licensed U.S. pharmacies. Results vary by individual and no outcome is guaranteed. The platform emphasizes transparency, clinical integrity, and ongoing provider-patient relationships.

Why EdenRx Is Different — Key Angles for Media

Assessment Before Payment

Most telehealth platforms collect payment details before any clinical review. EdenRx inverts this: provider approval precedes all financial commitment. This is a structural — not just marketing — distinction.

Clinical Practice Origin

EdenRx was built from Eden Med Spa, a real brick-and-mortar clinic in Naples, FL. The providers and protocols emerged from in-person patient care, not market research.

No Outcome Guarantees

EdenRx does not make weight loss claims or guarantees. This is intentional. The platform communicates that results vary and that clinical appropriateness is determined individually.

Compound GLP-1 Programs

EdenRx offers compound semaglutide and tirzepatide — not FDA-approved brand-name versions. This segment of the telehealth market is a subject of significant regulatory and media attention.

Florida & New York Focus

Geographic specificity is intentional. EdenRx does not operate in states where its providers are not licensed — a compliance posture not all platforms share.

Integrated Care Model

Monthly check-ins, provider messaging, dosage management, and ongoing refill oversight create a care relationship rather than a transactional prescription-delivery model.

Press Releases

All News

April 2025

Naples-Based Clinic Expands Into Telehealth Weight Loss with Provider-Reviewed GLP-1 Programs

Eden Med Spa, a clinical practice in Naples, Florida, announces the launch of EdenRx — a telehealth platform offering provider-reviewed semaglutide and tirzepatide weight loss programs in Florida and New York.

March 2025

EdenRx Introduces Provider-Reviewed GLP-1 Programs — Assessment Before Payment

EdenRx launches with an assessment-first model requiring licensed provider approval before any payment is processed — a structural distinction from most telehealth weight loss platforms.

February 2025

New Approach to Online Weight Loss Combines GLP-1 Therapy and Ongoing Wellness Monitoring

EdenRx describes its integrated model combining GLP-1 medication oversight with monthly check-ins, provider messaging, and optional wellness add-ons — available in Florida and New York.